(Q423467)

English

atazanavir

chemical compound

CGP-73547
ATZ
ATV
Zrivada
Latazanavir
Atazanavirum
Atazanavir

In more languages

Statements

type of chemical entity

0 references

1 reference

Atazanavir (English)

language of work or name

publication date

17 November 2015

chemical structure

Atazanavir.svg
342 × 209; 25 KB

1 reference

imported from Wikimedia project

German Wikipedia

704.39 dalton

1 reference

language of work or name

Atazanavir (English)

19 October 2016

stereoisomer of

Methyl [(5S,10R,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-{[4-(pyridin-2-yl)phenyl]methyl}-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate (non-preferred name)

2 references

based on heuristic

inferred from InChIKey

based on heuristic

inferred from InChI

chemical formula

C₃₈H₅₂N₆O₇

1 reference

language of work or name

Atazanavir (English)

19 November 2016

canonical SMILES

CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC

1 reference

language of work or name

Atazanavir (English)

19 November 2016

isomeric SMILES

CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC

1 reference

language of work or name

Atazanavir (English)

19 November 2016

defined daily dose

0.3 gram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=J05AE08

active ingredient in

1 reference

14 February 2018

World Health Organisation international non-proprietary name

atazanavir (English)

1 reference

language of work or name

atazanavir (English)

19 October 2016

significant drug interaction

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-rabeprazole

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

tenofovir disoproxil

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

idiopathic ventricular tachycardia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

Retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

muscular disease

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

muscular disease

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

legal status (medicine)

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

Australian pregnancy category B2

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category B

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Atazanavir

1 September 2017

subject has role

HIV protease inhibitors

1 reference

5 March 2018

essential medicine

0 references

1 reference

1 reference

Commons category

Atazanavir

0 references

CAS COVID-19 Anti-Viral Candidate Compounds

0 references

Identifiers

InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1

1 reference

language of work or name

Atazanavir (English)

19 November 2016

AXRYRYVKAWYZBR-GASGPIRDSA-N

2 references

language of work or name

Atazanavir (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

2 references

Global Substance Registration System

language of work or name

atazanavir (English)

19 November 2016

AXRYRYVKAWYZBR-GASGPIRDSA-N

CAS Common Chemistry

8 April 2021

https://commonchemistry.cas.org/detail?cas_rn=198904-31-3

1 reference

language of work or name

Atazanavir (English)

19 November 2016

1 reference

language of work or name

Atazanavir (English)

19 November 2016

Reaxys registry number

8101951

1 reference

language of work or name

atazanavir (English)

19 October 2016

mapping relation type

1 reference

language of work or name

ATAZANAVIR (English)

19 November 2016

1 reference

language of work or name

ATAZANAVIR (English)

19 November 2016

UniChem compound ID

1 reference

MassBank accession ID

MSBNK-Athens_Univ-AU214801

0 references

MSBNK-Athens_Univ-AU214802

0 references

MSBNK-Athens_Univ-AU214803

0 references

MSBNK-Athens_Univ-AU214804

0 references

MSBNK-Athens_Univ-AU214805

0 references

MSBNK-Athens_Univ-AU214807

0 references

MSBNK-Athens_Univ-AU214808

0 references

MSBNK-Athens_Univ-AU214809

0 references

MSBNK-Athens_Univ-AU214810

0 references

MSBNK-Athens_Univ-AU214811

0 references

MSBNK-Athens_Univ-AU214831

0 references

MSBNK-Athens_Univ-AU214832

0 references

MSBNK-Athens_Univ-AU214833

0 references

MSBNK-Athens_Univ-AU214834

0 references

MSBNK-Athens_Univ-AU214851

0 references

MSBNK-Athens_Univ-AU214852

0 references

MSBNK-Athens_Univ-AU214853

0 references

MSBNK-Athens_Univ-AU214854

0 references

MSBNK-Athens_Univ-AU214855

0 references

MSBNK-Eawag-EQ301201

0 references

MSBNK-Eawag-EQ301202

0 references

MSBNK-Eawag-EQ301203

0 references

MSBNK-Eawag-EQ301204

0 references

MSBNK-Eawag-EQ301205

0 references

MSBNK-Eawag-EQ301206

0 references

MSBNK-Eawag-EQ301251

0 references

MSBNK-Eawag-EQ301252

0 references

MSBNK-Eawag-EQ301253

0 references

MSBNK-Eawag-EQ301254

0 references

MSBNK-Eawag-EQ301255

0 references

MSBNK-Eawag-EQ301256

0 references

1 reference

Hazardous Substances Data Bank

publication date

28 October 2019

ATAZANAVIR (English)

10 May 2021

DSSTox substance ID

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

812-543-8

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate (English)

CAS no.: 198904-31-3 (English)

ECHA Substance Infocard ID

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

20 December 2018

methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate (English)

CAS no.: 198904-31-3 (English)

1 reference

language of work or name

Atazanavir (English)

publication date

17 November 2015

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

5 February 2021

MeSH concept ID

0 references

1 reference

Global Substance Registration System

language of work or name

atazanavir (English)

19 November 2016

1 reference

language of work or name

Atazanavir (English)

19 November 2016

Human Metabolome Database ID

1 reference

based on heuristic

inferred from InChIKey

1 reference

Global Substance Registration System

language of work or name

atazanavir (English)

19 November 2016

MedlinePlus drug identifier

0 references

NIAID ChemDB ID

1 reference

imported from Wikimedia project

English Wikipedia

1 reference

Global Substance Registration System

language of work or name

atazanavir (English)

19 November 2016

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

atazanavir (English)

19 October 2016

IEDB Epitope ID

1 reference

Immune Epitope Database and Analysis Resource

IEDB Epitope ID

1 March 2022

0 references

electronic Essential Medicines List medicine ID

0 references

1 reference

Freebase Data Dumps

publication date

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

PDB structure ID

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3OXX (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

2FXD (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

2FXE (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

2AQU (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3EM4 (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3EKY (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3EKW (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

2O4K (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3EL9 (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3EL1 (English)

19 October 2016

1 reference

Global Substance Registration System

language of work or name

atazanavir (English)

19 November 2016

WikiProjectMed ID

0 references

Sitelinks

Wikipedia(26 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswiki Category:Atazanavir

Retrieved from "https://www.wikidata.org/w/index.php?title=Q423467&oldid=2135942798"